Tumor necrosis factor α increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons

Brain Research

Volumn 981, Issue 1-2, 2003, Pages 133-142

  De, Alok ^a   Krueger, James M ^a   Simasko, Steven M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

AMPA; Calcium channel; Cultured neuron; Cytokine; Cytosolic Ca2+; Fura 2; Sleep; Tumor necrosis factor

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR ANTAGONIST; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CYCLOHEXIMIDE; FLUNARIZINE; FURA 2; NIFEDIPINE; POTASSIUM CHLORIDE; TETRODOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; AMINO ACID RECEPTOR AFFECTING AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; CALCIUM; OMEGA AGATOXIN TSUKUBA; OMEGA CONOTOXIN GVIA; OMEGA-AGATOXIN TSUKUBA; PEPTIDE FRAGMENT; PROTEIN SYNTHESIS INHIBITOR; SPIDER VENOM;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DEPOLARIZATION; DRUG EFFECT; FETUS; HIPPOCAMPUS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; TIME; UPREGULATION; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DOSE RESPONSE; DRUG INTERACTION; METABOLISM; MOUSE; NERVE CELL; NEWBORN;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANIMALS, NEWBORN; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGENTS; EXCITATORY AMINO ACID ANTAGONISTS; FURA-2; HIPPOCAMPUS; MICE; NEURONS; OMEGA-CONOTOXIN GVIA; PEPTIDE FRAGMENTS; POTASSIUM CHLORIDE; PROTEIN SYNTHESIS INHIBITORS; RATS; RECEPTORS, TUMOR NECROSIS FACTOR; SPIDER VENOMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0141522973     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02997-4     Document Type: Article

References (80)

1. Albensi B.C., Mattson M.P. Evidence for the involvement of TNF and NF-κB in hippocampal synaptic plasticity. Synapse. 35:2000;151-159.
2. Baram D., Vaday G.G., Salamon P., Drucker I., Hershkoviz R., Mekori Y.A. Human mast cells release metaloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNFα J. Immunol. 167:2001;4008-4016.
3. 2+ accumulation. Proc. Natl. Acad. Sci. USA. 92:1995;9328-9332.
4. Bazhenov M., Timofeev I., Steriade M., Sejnowski T.J. Model of thalamocortical slow-wave sleep oscillations and transitions to activated states. J. Neurosci. 22:2002;8691-8704.
5. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., von Zastrow M., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNFα Science. 295:2002;2282-2285.
6. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J. Invest. Med. 43:1995;227-235.
7. Boka G., Anglade P., Wallach D., Javoy-Agid Y., Hirsch E.C. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172:1994;151-154.
8. Botchkina G.I., Meistrell M.E. 3rd, Botchkina I.L., Tracey K.J. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol. Med. 3:1997;765-781.
9. Breder C.D., Tsujimoto M., Terano Y., Scott D.W., Saper C.B. Distribution and characterization of tumor necrosis factor-α-like immunoreactivity in the murine central nervous system. J. Comp. Neurol. 337:1993;543-567.
10. Bredow S., Guha-Thakurta N., Taishi P., Obal F. Jr., Krueger J.M. Diurnal variations of tumor necrosis factor α mRNA and α-tubulin mRNA in rat brain. Neuroimmunomodulation. 4:1997;84-90.
11. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2:1996;788-794.
12. Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron. 8:1992;189-198.
13. Cammer W. Effects of TNFα on immature and mature oligodendrocytes and their progenitors in vitro. Brain Res. 864:2000;213-219.
14. Caratsch C.G., Santoni A., Eusebi F. Interferon-α,β and tumor necrosis factor-α enhance the frequency of miniature end-plate potentials at rat neuromuscular junction. Neurosci. Lett. 166:1994;97-100.
15. Carlson N.G., Bacchi A., Rogers S.W., Gahring L.C. Nicotine blocks TNF-α-mediated neuroprotection to NMDA by an α -bungarotoxin-sensitive pathway. J. Neurobiol. 35:1998;29-36.
16. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA. 72:1975;3666-3670.
17. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 12:1994;139-153.
18. Cunningham A.J., Murray C.A., O'Neill L.A., Lynch M.A., O'Connor J.J. Interleukin-1 β (IL1-β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 203:1996;17-20.
19. De A., Simasko S.M., Taishi P., Churchill L., Krueger J.M. Calcium responses to growth hormone releasing hormone and interleukin-1β in cultured hypothalamic neurons is developmentally regulated. Sleep. 25:2002;A171-A172.
20. Denzoit F., Lang R. Rapid colorometric assay for cell growth and survival. J. Immunol. Methods. 89:1986;271-277.
21. Fang J., Wang Y., Krueger J.M. Mice lacking the TNF 55-kDa receptor fail to sleep after TNFalpha treatment. J. Neurosci. 17:1997;5949-5955.
22. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285:1991;199-212.
23. Floyd R.A., Krueger J.M. Diurnal variations of TNFα in the rat brain. Neuroreport. 8:1997;915-918.
24. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 22:(RC216):2002;1-7.
25. Furukawa K., Mattson M.P. The transcription factor NF-κB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-α in hippocampal neurons. J. Neurochem. 70:1998;1876-1886.
26. Gendron R.L., Nestel F.P., Lapp W.S., Baines M.G. Expression of tumor necrosis factor α in the developing nervous system. Int. J. Neurosci. 60:1991;129-136.
27. Glazner G.W., Mattson M.P. Differential effects of BDNF, ADNF9, and TNFα on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity. Exp. Neurol. 161:1999;442-452.
28. Grassi F., Mileo A.M., Monaco L., Punturieri A., Santoni A., Eusebi F. TNF-α increases the frequency of spontaneous miniature synaptic currents in cultured rat hippocampal neurons. Brain Res. 659:1994;226-230.
29. Ignatowski T.A., Noble B.K., Wright J.R., Gorfien J.L., Heffner R.R., Spengler R.N. Neuronal-associated tumor necrosis factor (TNFα): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. J. Neuroimmunol. 79:1997;84-90.
30. Klinkert W.E., Kojima K., Lesslauer W., Rinner W., Lassmann H., Wekerle H. TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol. 72:1997;163-168.
31. 2+ and induces a depolarization in cultured astroglial cells. Brain. 119:1996;2021-2027.
32. 2+ increase in cultured cortical astrocytes. Brain Res. 893:2001;237-243.
33. Krueger J.M., Toth L.A. Cytokines as regulators of sleep. Ann. NY Acad. Sci. 739:1994;299-310.
34. Krueger J.M., Obal F. Jr., Fang J. Humoral regulation of physiological sleep: cytokines and GHRH. J. Sleep Res. Suppl. 1:1999;53-59.
35. Kubota T., Li N., Guan Z., Brown R.A., Krueger J.M. Intrapreoptic microinjection of TNF-α enhances non-REM sleep in rats. Brain Res. 932:2002;37-44.
36. 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. Proc. Natl. Acad. Sci. USA. 82:1985;5756-5760.
37. Ledgerwood E.C., Pober J.S., Bradley J.R. Recent advances in the molecular basis of TNF signal transduction. Lab. Invest. 79:1999;1041-1050.
38. Lee Y.B., Yune T.Y., Baik S.Y., Shin Y.H., Du S., Rhim H., Lee E.B., Kim Y.C., Shin M.L., Markelonius G.J., Oh T.H. Role of tumor necrosis factor-α in neuronal and glial apoptosis after spinal cord injury. Exp. Neurol. 166:2000;190-195.
39. Lie B.L., Tunemoto D., Hemmi H., Mizukami Y., Fukuda H., Kikuchi H., Kato S., Numao N. Identification of the binding site of 55-kDa tumor necrosis factor receptor by synthetic peptides. Biochem. Biophys. Res. Commun. 188:1992;503-509.
40. Liu X.H., Xu H., Barks J.D. Tumor necrosis factor-α attenuates N-methyl-D-aspartate-mediated neurotoxicity in neonatal rat hippocampus. Brain Res. 85:1999;94-104.
41. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A.J., Old L., Bernard C.C. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4:1998;78-83.
42. Liu J., Ginis I., Spatz M., Hallenbeck J.M. Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-α and ceramide. Am. J. Physiol. Cell Physiol. 278:2000;C144-C153.
43. Luheshi G.N., Stefferl A., Turnbull A.V., Dascombe M.J., Brouwer S., Hopkins S.J., Rothwell N.J. Febrile response to tissue inflammation involves both peripheral and brain IL-1 and TNF-α in the rat. Am. J. Physiol. 272:1997;R862-R868.
44. Marino M.W., Dunn A., Grail D., Inglese M., Noguchi Y., Richards E., Jungbluth A., Wada H., Moore M., Williamson B., Basu S., Old L.J. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;8093-8098.
45. Meistrell M.E. 3rd, Botchkina G.I., Wang H., Di Santo E., Cockroft K.M., Bloom O., Vishnubhakat J.M., Chezzi P., Tracey K.J. Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock. 8:1997;341-348.
46. Merrill J.E. Tumor necrosis factor α, interleukin1 and related cytokines in brain development: normal and pathological. Dev. Neurosci. 14:1992;1-10.
47. Olivera B.M., Miljanich G.P., Ramachandran J., Adams M.E. Calcium channel diversity and neurotransmitter release: the ω-conotoxins and ω-agatoxins. Annu. Rev. Biochem. 63:1994;823-867.
48. Peschon J.J., Toorance D.S., Stocking K.L., Glaccum M.B., Otten C., Willis C.R., Charrier K., Morrissey P.J., Ware C.B., Mohler K.M. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160:1998;943-952.
49. Plata-Salaman C.R. Cytokines and feeding. News Physiol. Sci. 13:1998;298-304.
50. Plata-Salaman C.R. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition. 16:2000;1009-1012.
51. Plata-Salaman C.R., Oomura Y., Kai Y. Tumor necrosis factor and interleukin-1 β: suppression of food intake by direct action in the central nervous system. Brain Res. 448:1988;106-114.
52. 2+ mobilisation and stress kinases in cultured sensory neurons. Neuropharmacology. 42:2002;93-106.
53. Prehn J.H. Marked diversity in the action of growth factors on N-methyl-D-aspartate-induced neuronal degeneration. Eur. J. Pharmacol. 306:1996;81-88.
54. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulou L., Kollias G. TNF-α transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72:1997;137-141.
55. 125I-labeled human necrosis factor (LuKII) to specific cell surface receptors. J. Exp. Med. 162:1985;1099-1104.
56. Saper C.B., Breder C.D. Endogenous pyrogens in the CNS: role in the febrile response. Prog. Brain Res. 93:1992;419-428.
57. Sawada M., Kondo N., Suzumura A., Marunouchi T. Production of tumor necrosis factor-α by microglia and astrocytes in culture. Brain Res. 491:1989;394-397.
58. Scherbel U., Raghupathi R., Nakamura M., Saatman K.E., Trojanowski J.Q., Neugebauer E., Marino M.W., McIntosh T.K. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. USA. 96:1999;8721-8726.
59. Schluter D., Deckert M. The divergent role of tumor necrosis factor receptors in infectious diseases. Microbes Infect. 2:2000;1285-1292.
60. Schubert P., Ogata T., Marchini C., Ferroni S., Rudolphi K. Protective mechanisms of adenosine in neurons and glial cells. Ann. NY Acad. Sci. 825:1997;1-10.
61. Schubert P., Ogata T., Miyazaki H., Marchini C., Ferroni S., Rudolphi K. Pathological immuno-reactions of glial cells in Alzheimer's disease and possible sites of interference. J. Neural Transm. Suppl. 54:1998;167-174.
62. Selmaj K.W., Raines C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
63. Sharief M.K. Cytokines in multiple sclerosis: pro-inflammatory or pro-remyelination? Mult. Scler. 4:1998;169-173.
64. Shoham S., Davenne D., Cady A.B., Dinarello C.A., Krueger J.M. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am. J. Physiol. 253:1987;R142-R149.
65. Simasko S.M., Boyadjieva N., De A., Sarkar D.K. Effect of ethanol on calcium regulation in rat fetal hypothalamic cells in culture. Brain Res. 824:1999;89-96.
66. 2+ currents in cultured sympathetic neurons. J. Neurosci. 12:1992;2665-2671.
67. Sortino M.A., Condorelli F., Vancheri C., Canonico P.L. Tumor necrosis factor-α induces apoptosis in immortalized hypothalamic neurons: involvement of ceramide-generating pathways. Endocrinology. 140:1999;4841-4849.
68. Spedding M., Paoletti R. III. Classification of calcium channels and sites of action of drugs modifying channel function. Pharmacol. Rev. 44:1992;363-376.
69. Sugishita K., Kinugawa K., Shimizu T., Harada K., Matsui H., Takahashi T., Serizawa T., Kohmoto O. Cellular basis for the acute inhibitory effects of IL-6 and TNF-α on excitation-contraction coupling. J. Mol. Cell. Cardiol. 31:1999;1457-1467.
70. Takahashi S., Kapas L., Krueger J.M. A tumor necrosis factor (TNF) receptor fragment attenuates TNF-α- and muramyl dipeptide-induced sleep and fever in rabbits. J. Sleep Res. 5:1996;106-114.
71. Takahashi S., Kapas L., Seyer J.M., Wang Y., Krueger J.M. Inhibition of tumor necrosis factor attenuates physiological sleep in rabbits. Neuroreport. 7:1996;642-646.
72. Tancredi V., D'Arcangelo G., Grassi F., Tarroni P., Palmieri G., Santoni A., Eusebi F. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci. Lett. 146:1992;176-178.
73. Teramoto T., Niidrome T., Miyagawa T., Nishizawa Y., Katayama K., Sawada K. Two types of calcium channels sensitive to ω-agatoxin-TK in cultured rat hippocampal neurones. Neuroreport. 6:1995;1684-1688.
74. Tsukamoto T., Ishikawa M., Yamamoto T. Suppressive effects of TNF-α on myelin formation in vitro. Acta Neurol. Scand. 91:1995;71-75.
75. Venters H.D., Tang Q., Liu Q., VanHoy R.W., Danzler R., Kelley K.W. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc. Natl. Acad. Sci. USA. 96:1999;9879-9884.
76. Vitkovic L., Konsman J.P., Bockaert J., Dantzer R., Homburger V., Jacque C. Cytokine signals propagate through the brain. Mol. Psychiatry. 5:2000;604-615.
77. Wilde G.J.C., Pringle A.K., Sundstrom L.E., Mann D.A., Iannotti F. Attenuation and augmentation of ischaemia-related neuronal death by tumor necrosis factor-α in vitro. Eur. J. Neurosci. 12:2000;3863-3870.
78. Wilkinson M.K., Earle M.L., Triggle C.R., Barnes S. Interleukin-1β, tumor necrosis factor-α, and LPS enhances calcium channel currents in isolated vascular smooth muscle cells of rat tail artery. FASEB J. 10:1996;785-791.
79. Wolvers D.A., Marquette C., Berkenbosch F., Homer F. Tumor necrosis factor-α: specific binding sites in rodent brain and pituitary gland. Eur. Cytokine Netw. 4:1993;377-381.
80. Yang L., Lindholm K., Konishi Y., Li R., Shen Y. Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J. Neurosci. 22:2002;3025-3032.